Literature DB >> 29192975

Importance of recognition and improved treatment for antimelanoma differentiation-associated protein 5-associated dermatomyositis.

A Caplan1, S Imadojemu2, V P Werth1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29192975      PMCID： PMC5726408          DOI： 10.1111/bjd.15944

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis.

Authors:  Toshinori Takada; Ami Aoki; Katsuaki Asakawa; Takuro Sakagami; Hiroshi Moriyama; Ichiei Narita; Shinji Sato
Journal:  Respir Med       Date:  2015-07-09       Impact factor: 3.415

2.  Intravenous immunoglobulin contributes to the control of antimelanoma differentiation-associated protein 5 antibody-associated dermatomyositis with palmar violaceous macules/papules.

Authors:  H Koguchi-Yoshioka; N Okiyama; K Iwamoto; Y Matsumura; T Ogawa; S Inoue; R Watanabe; M Fujimoto
Journal:  Br J Dermatol       Date:  2017-10-11       Impact factor: 9.302

3.  Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases.

Authors:  Ning Li; Minglang Zhao; Julio Hilario-Vargas; Phillip Prisayanh; Simon Warren; Luis A Diaz; Derry C Roopenian; Zhi Liu
Journal:  J Clin Invest       Date:  2005-11-10       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.